Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Maha N Mian

Biographic Data

ID3824440
NAMEMaha N Mian
GIVEN NAMESMaha N
FAMILY NAMEMian
SIGNATUREMIAN M N
AFFILIATIONSUniversity at Albany, State University of New York
ORCID0000-0001-7051-7820
VERIFIEDYes
TOTAL WORKS13
TOTAL CITATIONS2
WORKS AS AUTHOR13
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2018
LATEST PUBLICATION YEAR2025
H-INDEX1
  • Substance use and mental health factors associated with self-reported higher risk cannabis use among people with HIV screened in primary care

    Open Access•Maha N Mian, Varada Sarovar et al.•ARTICLE•BMC Public Health•2025

    Black race, anxiety and tobacco use were associated with higher risk for CUD among PWH in a multivariable model. Clinical efforts to screen and provide interventions for preventing CUD alongside anxiety and tobacco use among PWH should be evaluated

  • Psychedelic Augmentation of 12-Step Engagement

    Open Access•Nicky J Mehtani, Maha N Mian et al.•ARTICLE•Journal of Psychoactive Drugs•2025

    Amid an evolving psychedelic drug policy landscape and limitations of existing substance use disorder (SUD) treatments, a novel addiction recovery paradigm has emerged involving augmentation of 12-Step program engagement with therapeutic psychedelic use. A preliminary qualitative analysis was initiated to describe this movement by examining real-world experiences of participants in remission from alcohol, opioid, and stimulant use disorders. Betw…

  • Latent Classes of Lifetime Use of Seven Hallucinogens in the United States

    Open Access•Meredith C Meacham, Maha N Mian et al.•ARTICLE•Journal of Psychoactive Drugs•2025

    Interest in and use of hallucinogens appears to be growing in the United States, yet less is known about the use of multiple hallucinogens. The aims of this study are to characterize subgroups of lifetime hallucinogen use and to identify sociodemographic correlates of these subgroups. Latent class models were fit using 2021-2022 National Survey on Drug Use and Health (NSDUH) data on a sub-sample of individuals who reported having ever used any ha…

  • Social Workers’ Attitudes and Beliefs about MDMA-Assisted Therapy for Adolescents with PTSD

    Open Access•Maha N Mian, Jordan Horan et al.•ARTICLE•Social Work•2025

    Given the widespread interest and ongoing study on MDMA-assisted therapy (MDMA-AT) for PTSD, its implications for unique populations—such as adolescents—require further understanding. Social workers will likely play a crucial role in the potential implementation of this intervention, but their perspectives remain unknown. The study includes 222 social workers randomized to read one of two vignettes about MDMA-AT or selective serotonin reuptake in…

  • Expectancies for Subjective and Antidepressant Effects in Psilocybin Users

    Open Access•M Earleywine, Maha N Mian et al.•ARTICLE•Journal of Humanistic Psychology•2023•References: 74

    Expectancy effects for many psychoactive substances appear to play a role in consumption, problematic use, subjective responses to acute administration, and subsequent effects. Expectancies of psychedelics have received little attention in published research despite their reputation for creating dramatic changes in subjective state. Psilocybin-assisted treatment (PAT) improves depression, but details of associated expected effects remain incomple…

  • Savoring as an intervention for cannabis use

    Maha N Mian, M Earleywine•ARTICLE•Addiction Research & Theory•2022

    Although savoring appears protective against cannabis problems, researchers have yet to apply it to reduce cannabis-related harms. Study I surveyed a large (N = 557, Mage = 36.9, 50.1% Male, 73% White) sample who rated a hypothetical savoring intervention as feasible and acceptable; those who savored more reported fewer cannabis problems, less use, and less intoxication. Study II, a pilot experiment (N = 26, Mage = 18, 34.6% Male, 42% White), ran…

  • Age-Related Differences in Cannabis Product Use

    Luna F Ueno, Maha N Mian et al.•ARTICLE•Journal of Psychoactive Drugs•2021

    Cannabis use varies with age and gender, but less is known regarding specific product choices. Previous work suggests that older adults are inclined to stick to the more "classic" and familiar, while "novel" products are more likely to appeal to younger populations. We examined cross-sectional, retrospective data to determine whether the type of cannabis products used varied according to participant age ( N = 1406, 71.3% female). The extensive li…

  • Symptom specificity of ayahuasca's effect on depressive symptoms

    Open Access•C S Gilbert, M Earleywine et al.•ARTICLE•Journal of Psychedelic Studies•2021•Cited by: 2•References: 41

    BackgroundAyahuasca's effects on symptoms of depression have generated considerable optimism. Clients frequently report more concern about some symptoms than others, and available treatments alter symptoms differentially. Few studies address the symptom specificity of this psychoactive brew.AimsWe examined self-reported effects of ayahuasca on the individual symptoms of depression assessed by the 10-item short-form of Center for Epidemiological S…

  • Confirming Savoring’s Link to Fewer Cannabis Problems

    Maha N Mian, Brianna R Altman et al.•ARTICLE•Journal of Psychoactive Drugs•2020

    Savoring has covaried inversely with cannabis problems and moderated the association between cannabis use and negative consequences related to use. Research has not yet addressed the acceptability of savoring interventions for cannabis users. The present study aimed to replicate the finding of savoring as a protective factor against problems for cannabis users. The second aim of the study was to examine preferences for a savoring intervention amo…

  • The Novelty of Ayahuasca Scale and the prediction of intentions to use

    Open Access•Brianna R Altman, Maha N Mian et al.•ARTICLE•Journal of Psychedelic Studies•2020•References: 48

    ObjectiveGiven the growing popularity of ayahuasca and other hallucinogens, we sought to identify related expectancies and their role in why people might use this psychoactive brew rather than classic hallucinogens like LSD or psilocybin.MethodExperienced users (N = 139) completed an online survey about their use of hallucinogens (including ayahuasca), how their ayahuasca experiences differed from those with other hallucinogens, as well as their …

  • Cannabis Expectancies for Sleep

    Brianna R Altman, Maha N Mian et al.•ARTICLE•Journal of Psychoactive Drugs•2019

    Up to 35% of adults in the United States suffer from sleep disturbances, which covary with a host of negative mental and physical health outcomes. Previous research suggests that cannabis' sedative effects may be associated with improved sleep. The present study examined the self-reported effect of cannabis use on individual's sleep-related problems. Participants included 311 individuals recruited online, who reported both sleep-related problems …

  • Ayahuasca’s Antidepressant Effects Covary with Behavioral Activation as Well as Mindfulness

    Maha N Mian, Brianna R Altman et al.•ARTICLE•Journal of Psychoactive Drugs•2019

    Ayahuasca, a plant-based hallucinogen that serves as a spiritual medicine in South America, has improved depression in at least one placebo-controlled clinical trial. Case studies suggest that dramatic behavioral changes often follow the Ayahuasca ceremony, but most explanations of antidepressant effects focus on changes in mindfulness. This study investigated whether both mindfulness and behavioral activation might contribute to these anti-depre…

  • The Role of Impulsivity and Expectancies in Predicting Marijuana Use

    Rachel Luba, M Earleywine et al.•ARTICLE•Journal of Psychoactive Drugs•2018

    Impulsivity and substance use covary. Smith and Anderson's acquired preparedness model proposes that impulsivity predicts substance use through a mediational model such that substance use expectancies mediate the relation between impulsivity and drug use. The present study seeks to examine the relation between positive urgency, an important component of impulsivity with specific relations to substance use behavior, marijuana expectancies, and mar…

  • Symptom specificity of ayahuasca's effect on depressive symptoms

    Open Access•C S Gilbert, M Earleywine et al.•ARTICLE•Journal of Psychedelic Studies•2021•Cited by: 2•References: 41

    BackgroundAyahuasca's effects on symptoms of depression have generated considerable optimism. Clients frequently report more concern about some symptoms than others, and available treatments alter symptoms differentially. Few studies address the symptom specificity of this psychoactive brew.AimsWe examined self-reported effects of ayahuasca on the individual symptoms of depression assessed by the 10-item short-form of Center for Epidemiological S…

  • The Role of Impulsivity and Expectancies in Predicting Marijuana Use

    Rachel Luba, M Earleywine et al.•ARTICLE•Journal of Psychoactive Drugs•2018

    Impulsivity and substance use covary. Smith and Anderson's acquired preparedness model proposes that impulsivity predicts substance use through a mediational model such that substance use expectancies mediate the relation between impulsivity and drug use. The present study seeks to examine the relation between positive urgency, an important component of impulsivity with specific relations to substance use behavior, marijuana expectancies, and mar…

  • Cannabis Expectancies for Sleep

    Brianna R Altman, Maha N Mian et al.•ARTICLE•Journal of Psychoactive Drugs•2019

    Up to 35% of adults in the United States suffer from sleep disturbances, which covary with a host of negative mental and physical health outcomes. Previous research suggests that cannabis' sedative effects may be associated with improved sleep. The present study examined the self-reported effect of cannabis use on individual's sleep-related problems. Participants included 311 individuals recruited online, who reported both sleep-related problems …

  • Ayahuasca’s Antidepressant Effects Covary with Behavioral Activation as Well as Mindfulness

    Maha N Mian, Brianna R Altman et al.•ARTICLE•Journal of Psychoactive Drugs•2019

    Ayahuasca, a plant-based hallucinogen that serves as a spiritual medicine in South America, has improved depression in at least one placebo-controlled clinical trial. Case studies suggest that dramatic behavioral changes often follow the Ayahuasca ceremony, but most explanations of antidepressant effects focus on changes in mindfulness. This study investigated whether both mindfulness and behavioral activation might contribute to these anti-depre…

  • Confirming Savoring’s Link to Fewer Cannabis Problems

    Maha N Mian, Brianna R Altman et al.•ARTICLE•Journal of Psychoactive Drugs•2020

    Savoring has covaried inversely with cannabis problems and moderated the association between cannabis use and negative consequences related to use. Research has not yet addressed the acceptability of savoring interventions for cannabis users. The present study aimed to replicate the finding of savoring as a protective factor against problems for cannabis users. The second aim of the study was to examine preferences for a savoring intervention amo…

  • The Novelty of Ayahuasca Scale and the prediction of intentions to use

    Open Access•Brianna R Altman, Maha N Mian et al.•ARTICLE•Journal of Psychedelic Studies•2020•References: 48

    ObjectiveGiven the growing popularity of ayahuasca and other hallucinogens, we sought to identify related expectancies and their role in why people might use this psychoactive brew rather than classic hallucinogens like LSD or psilocybin.MethodExperienced users (N = 139) completed an online survey about their use of hallucinogens (including ayahuasca), how their ayahuasca experiences differed from those with other hallucinogens, as well as their …

  • Age-Related Differences in Cannabis Product Use

    Luna F Ueno, Maha N Mian et al.•ARTICLE•Journal of Psychoactive Drugs•2021

    Cannabis use varies with age and gender, but less is known regarding specific product choices. Previous work suggests that older adults are inclined to stick to the more "classic" and familiar, while "novel" products are more likely to appeal to younger populations. We examined cross-sectional, retrospective data to determine whether the type of cannabis products used varied according to participant age ( N = 1406, 71.3% female). The extensive li…

  • Symptom specificity of ayahuasca's effect on depressive symptoms

    Open Access•C S Gilbert, M Earleywine et al.•ARTICLE•Journal of Psychedelic Studies•2021•Cited by: 2•References: 41

    BackgroundAyahuasca's effects on symptoms of depression have generated considerable optimism. Clients frequently report more concern about some symptoms than others, and available treatments alter symptoms differentially. Few studies address the symptom specificity of this psychoactive brew.AimsWe examined self-reported effects of ayahuasca on the individual symptoms of depression assessed by the 10-item short-form of Center for Epidemiological S…

  • Savoring as an intervention for cannabis use

    Maha N Mian, M Earleywine•ARTICLE•Addiction Research & Theory•2022

    Although savoring appears protective against cannabis problems, researchers have yet to apply it to reduce cannabis-related harms. Study I surveyed a large (N = 557, Mage = 36.9, 50.1% Male, 73% White) sample who rated a hypothetical savoring intervention as feasible and acceptable; those who savored more reported fewer cannabis problems, less use, and less intoxication. Study II, a pilot experiment (N = 26, Mage = 18, 34.6% Male, 42% White), ran…

  • Expectancies for Subjective and Antidepressant Effects in Psilocybin Users

    Open Access•M Earleywine, Maha N Mian et al.•ARTICLE•Journal of Humanistic Psychology•2023•References: 74

    Expectancy effects for many psychoactive substances appear to play a role in consumption, problematic use, subjective responses to acute administration, and subsequent effects. Expectancies of psychedelics have received little attention in published research despite their reputation for creating dramatic changes in subjective state. Psilocybin-assisted treatment (PAT) improves depression, but details of associated expected effects remain incomple…

  • Substance use and mental health factors associated with self-reported higher risk cannabis use among people with HIV screened in primary care

    Open Access•Maha N Mian, Varada Sarovar et al.•ARTICLE•BMC Public Health•2025

    Black race, anxiety and tobacco use were associated with higher risk for CUD among PWH in a multivariable model. Clinical efforts to screen and provide interventions for preventing CUD alongside anxiety and tobacco use among PWH should be evaluated

  • Psychedelic Augmentation of 12-Step Engagement

    Open Access•Nicky J Mehtani, Maha N Mian et al.•ARTICLE•Journal of Psychoactive Drugs•2025

    Amid an evolving psychedelic drug policy landscape and limitations of existing substance use disorder (SUD) treatments, a novel addiction recovery paradigm has emerged involving augmentation of 12-Step program engagement with therapeutic psychedelic use. A preliminary qualitative analysis was initiated to describe this movement by examining real-world experiences of participants in remission from alcohol, opioid, and stimulant use disorders. Betw…

  • Latent Classes of Lifetime Use of Seven Hallucinogens in the United States

    Open Access•Meredith C Meacham, Maha N Mian et al.•ARTICLE•Journal of Psychoactive Drugs•2025

    Interest in and use of hallucinogens appears to be growing in the United States, yet less is known about the use of multiple hallucinogens. The aims of this study are to characterize subgroups of lifetime hallucinogen use and to identify sociodemographic correlates of these subgroups. Latent class models were fit using 2021-2022 National Survey on Drug Use and Health (NSDUH) data on a sub-sample of individuals who reported having ever used any ha…

  • Social Workers’ Attitudes and Beliefs about MDMA-Assisted Therapy for Adolescents with PTSD

    Open Access•Maha N Mian, Jordan Horan et al.•ARTICLE•Social Work•2025

    Given the widespread interest and ongoing study on MDMA-assisted therapy (MDMA-AT) for PTSD, its implications for unique populations—such as adolescents—require further understanding. Social workers will likely play a crucial role in the potential implementation of this intervention, but their perspectives remain unknown. The study includes 222 social workers randomized to read one of two vignettes about MDMA-AT or selective serotonin reuptake in…

Psychiatry (12 works) · Psychology (10 works) · Cannabis and Cannabinoid Research (9 works) · Clinical Psychology (8 works) · Psychedelics and Drug Studies (8 works) · Clinical Psychology (7 works) · Medicine (6 works) · Cannabis (5 works) · Biochemical Analysis and Sensing Techniques (4 works) · Hallucinogen (4 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae